CME Group Inc.: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Oct 24, 2025 and accepted by EDGAR at Oct 24, 2025, 14:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $1.54bn | us-gaap:Revenues |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $4.87bn | us-gaap:Revenues |
| Operating income | 3 months2025-07-01 to 2025-09-30 | $972.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-01-01 to 2025-09-30 | $3.21bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $269.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $862.8m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | $2.49 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | $7.92 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | $2.49 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | $7.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 360,422,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 360,330,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | $3.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-01-01 to 2025-09-30 | $51.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2025-01-01 to 2025-09-30 | $3.48bn | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2025-09-30 | $2.45bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-09-30 | $152.80bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-09-30 | $187.14bn | us-gaap:Assets |
| Current liabilities | At period end2025-09-30 | $149.59bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-09-30 | $158.95bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-09-30 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-09-30 | $28.19bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001156375-25-000206. Last ingested by Listed: Nov 3, 2026, 22:14 ET. Listed shows no prices and gives no investment advice.